
Glimzab MV 1mg/500mg/0.3mg Tablet
Marketer
Neucure Lifesciences Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimzab MV 1mg/500mg/0.3mg Tablet
Glimzab MV 1mg/500mg/0.3mg tablets are antidiabetic medications combining multiple agents for adult type 2 diabetes management. This formulation assists in regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, incorporating a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most common adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its hypoglycemic effect. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling (edema), blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.
Uses of Glimzab MV 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glimzab MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimzab MV 1mg/500mg/0.3mg tablets on an empty stomach.
Common Side effects of Glimzab MV 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimzab MV 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimzab MV 1mg/500mg/0.3mg Tablets should be administered on an empty stomach.
How Glimzab MV 1mg/500mg/0.3mg Tablet works:
Each Glimzab MV tablet (1mg/500mg/0.3mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimzab MV 1mg/500mg/0.3mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimzab MV 1mg/500mg/0.3mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimzab MV 1mg/500mg/0.3mg tablets while breastfeeding is likely unsafe. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Glimzab MV 1mg/500mg/0.3mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimzab MV 1mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Low initial doses are usually prescribed for individuals with mild to moderate hepatic dysfunction; however, its administration is contraindicated in those with severe liver disease.
What if you forget to take Glimzab MV 1mg/500mg/0.3mg Tablet :
Should you forget to take your Glimzab MV 1mg/500mg/0.3mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Glimzab MV 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
